Clinical Trials Directory

Trials / Completed

CompletedNCT03390114

Cognitive Behavioral Therapy to Treat Insomnia in Persons With HIV Infection

Internet-Based Cognitive Behavioral Therapy to Treat Insomnia in HIV: A Pilot Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Indiana University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this preliminary study is to determine the efficacy of an internet-based treatment program for insomnia for HIV-infected persons.

Detailed description

The primary objective of this pilot trial is to compare 10-week changes in Insomnia Severity Index (ISI) scores in HIV-infected adults with clinically relevant insomnia severity and who are already receiving virologically suppressive antiretroviral therapy (ART) and are then randomized to either treatment with the SHUTi cognitive behavioral therapy program or to Usual Care (UC). A total of 100 persons with HIV may be screened to identify the 32 participants to be enrolled and randomized into the pilot trial. These participants will be ≥ 18 years old, have been receiving antiretroviral therapy with an HIV viral load \< 75 copies/mL within three months of the Entry Visit, and have an ISI score ≥ 15 within three months of the Entry Visit. These participants will be randomized 1:1 (stratified by age \<40 vs. ≥ 40 years) to either insomnia treatment with the SHUTi cognitive behavioral therapy program (N=16) or usual care (N=16).

Conditions

Interventions

TypeNameDescription
BEHAVIORALSHUTiSHUTi consists of six, 40-minute, weekly sessions during which the intervention components of stimulus control, sleep restriction, sleep hygiene, cognitive restructuring, and relapse prevention are delivered. Each SHUTi session has the same structure: the main content, a homework screen with options, and a summary of the main points.

Timeline

Start date
2018-05-01
Primary completion
2019-07-31
Completion
2019-12-31
First posted
2018-01-04
Last updated
2021-02-21
Results posted
2021-02-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03390114. Inclusion in this directory is not an endorsement.